Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells.

Journal of the National Cancer Institute - 21 May 2003

Hu Yu-Long, Albanese Chris, Pestell Richard G, Jaffe Robert B

Abstract excerpt

BACKGROUND: Lysophosphatidic acid (LPA), at concentrations present in ascitic fluid, indirectly stimulates the growth of malignant ovarian tumors by increasing the expression of vascular endothelial growth factor (VEGF) in ovarian cancer cells. We investigated whether LPA could also directly prom...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cyclin D1
Share to I-kappa B Proteins
Share to Luciferases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lysophospholipids

Share to NF-kappa B

Share to Receptors, G-Protein-Coupled

Share to Receptors, Vascular Endothelial Growth Factor

Share to RNA, Neoplasm

Source

Identifiers

PMID: 12759391
DOI: 10.1093/jnci/95.10.733

Genes

LPA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-12759391-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Dual mechanisms for lysophosphatidic acid stimulation of human ovarian carcinoma cells.PMID 12759391Read ↗

Lysophosphatidic Acid Activates Lipogenic Pathways and de Novo Lipid Synthesis in Ovarian Cancer CellsSemantic proximity Read ↗

Signaling mechanisms responsible for lysophosphatidic acid-induced urokinase plasminogen activator expression in ovarian cancer cells.Semantic proximity Read ↗

Lysophosphatidic acid receptors in cancer pathobiology.Semantic proximity Read ↗

LPA3 Is a Precise Therapeutic Target And Potential Biomarker For Ovarian CancerSemantic proximity Read ↗

Mutation of Y179 on phospholipase D2 (PLD2) upregulates DNA synthesis in a PI3K-and Akt-dependent manner.Semantic proximity Read ↗

Diverse effects of LPA receptors on cell motile activities of cancer cellsSemantic proximity Read ↗

Functional Regulation of Phospholipase D Expression in Cancer and InflammationSemantic proximity Read ↗

A new signaling pathway (JAK-Fes-phospholipase D) that is enhanced in highly proliferative breast cancer cells.Semantic proximity Read ↗

mTOR-dependent suppression of protein phosphatase 2A is critical for phospholipase D survival signals in human breast cancer cells.Semantic proximity Read ↗

Molecular mechanisms underlying mifepristone's agonistic action on ovarian cancer progressionSemantic proximity Read ↗

Anacardic acid enhances the proliferation of human ovarian cancer cells.Semantic proximity Read ↗

Involvement of phospholipase D2 in lysophosphatidate-induced transactivation of platelet-derived growth factor receptor-beta in human bronchial epithelial cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.